Displaying 41 - 50 of 241 results
Cancer Research – Looking Back, Moving Forward
June 29, 2023 — After funding cancer research for over sixty years, we take a look back at the advances made understanding cancer in animals and look forward to questions that still need to be answered.
Golden Retriever Lifetime Study Reaches 500 Diagnoses of 4 Major Cancers
July 26, 2023 — Morris Animal Foundation recently reached its goal of 500 cumulative diagnoses of four major canine cancers.
Taking Stock of the Golden Retriever Lifetime Study
July 24, 2023 – As the Golden Retriever Lifetime Study turns 11 years old, it’s a great time for some updates on our Study cohort as well as additional Study-related research initiatives underway.
Bowie, the Dancing Dog, Faces Cancer With Loving Support From His Owner
March 15, 2016 – Meet champion freestyle dog dancer Bowie and his owner Laurie Sullivan and learn how the pair coped with Bowie's hemangiosarcoma diagnosis.
It's More Fun with Goldens
March 26, 2019 – Golden Retriever Lifetime Study participant Julie Cuenod talks about how losing her dog Teddie inspired her to enroll her dogs Ellie and Tate.
Morris Animal Foundation Golden Retriever Lifetime Study Celebrates 10 Years
August 29, 2022 – The Foundation announces its Golden Retriever Lifetime Study has reached its 10-year Anniversary.
Upcoming Webinar to Inform Pet Parents About a Common, Deadly Canine Cancer
May 31, 2023 — Morris Animal Foundation is hosting a webinar next month in collaboration with TEDxMileHigh to provide pet parents with tools to recognize the clinical signs and navigate a hemangiosarcoma diagnosis.
More Research, More Education – Making the World a Better Place for Wildlife
November 27, 2018 – Learn about Betsy Robinson & Steve Gehman's work to help resource managers and conservationists protect forest habitats and biological diversity.
Finding a New Purpose After Cancer
April 27, 2020 – Meet Marejka Shaevitz, veterinarian and cancer survivor, and learn how her experience led her to become a veterinary oncologist.